Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers
Top Cited Papers
- 1 September 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (9) , 3564-3568
- https://doi.org/10.1128/aac.00220-10
Abstract
Foreign travel has been suggested to be a risk factor for the acquisition of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. To our knowledge, this has not previously been demonstrated in a prospective study. Healthy volunteers traveling outside Northern Europe were enrolled. Rectal swabs and data on potential travel-associated risk factors were collected before and after traveling. A total of 105 volunteers were enrolled. Four of them did not complete the study, and one participant carried ESBL-producing Escherichia coli before travel. Twenty-four of 100 participants with negative pretravel samples were colonized with ESBL-producing Escherichia coli after the trip. All strains produced CTX-M enzymes, mostly CTX-M-15, and some coproduced TEM or SHV enzymes. Coresistance to several antibiotic subclasses was common. Travel to India was associated with the highest risk for the acquisition of ESBLs (88%; n = 7). Gastroenteritis during the trip was an additional risk factor (P = 0.003). Five of 21 volunteers who completed the follow-up after 6 months had persistent colonization with ESBLs. This is the first prospective study demonstrating that international travel is a major risk factor for colonization with ESBL-producing Enterobacteriaceae. Considering the high acquisition rate of 24%, it is obvious that global efforts are needed to meet the emergence and spread of CTX-M enzymes and other antimicrobial resistances.Keywords
This publication has 33 references indexed in Scilit:
- Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004–2007)International Journal of Antimicrobial Agents, 2009
- Molecular Characteristics of Travel-Related Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from the Calgary Health RegionAntimicrobial Agents and Chemotherapy, 2009
- Community‐Onset Genitourinary Tract Infection due to CTX‐M‐15–ProducingEscherichia coliamong Travelers to the Indian Subcontinent in New ZealandClinical Infectious Diseases, 2008
- Duration of Stool Colonization in Patients Infected with Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniaeClinical Infectious Diseases, 2008
- Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coliClinical Microbiology & Infection, 2008
- Comparison between O Serotyping Method and Multiplex Real-Time PCR To Identify DiarrheagenicEscherichia coliin TaiwanJournal of Clinical Microbiology, 2007
- Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase– and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004)Diagnostic Microbiology and Infectious Disease, 2005
- Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)Diagnostic Microbiology and Infectious Disease, 2005
- Analysis of clustered matched‐pair dataStatistics in Medicine, 2003
- Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratoriesDiagnostic Microbiology and Infectious Disease, 2002